1、Verdijk RM. An update of ocular adnexal lymphomas[ J]. Diagn
Histopathol, 2015, 21(1): 26-33.Verdijk RM. An update of ocular adnexal lymphomas[ J]. Diagn
Histopathol, 2015, 21(1): 26-33.
2、Knop N, Knop E, et al. Conjunctiva-associated lymphoid tissue in the
human eye[ J]. Invest Ophthalmol Vis Sci, 2000, 41(6): 1270-1279.Knop N, Knop E, et al. Conjunctiva-associated lymphoid tissue in the
human eye[ J]. Invest Ophthalmol Vis Sci, 2000, 41(6): 1270-1279.
3、Wieczorek R, Jakobiec FA, Sacks EH, et al. The immunoarchitecture
of the normal human lacrimal gland. Relevancy for understanding
pathologic conditions[ J]. Ophthalmology, 1988, 95(1): 100-109.Wieczorek R, Jakobiec FA, Sacks EH, et al. The immunoarchitecture
of the normal human lacrimal gland. Relevancy for understanding
pathologic conditions[ J]. Ophthalmology, 1988, 95(1): 100-109.
4、Andrew NH, Coupland SE, Pirbhai A, et al. Lymphoid hyperplasia
of the orbit and ocular adnexa: A clinical pathologic review[ J]. Surv
Ophthalmol, 2016, 61(6): 778-790.Andrew NH, Coupland SE, Pirbhai A, et al. Lymphoid hyperplasia
of the orbit and ocular adnexa: A clinical pathologic review[ J]. Surv
Ophthalmol, 2016, 61(6): 778-790.
5、Farmer JP, Lamba M, Lamba WR, et al. Lymphoproliferative lesions
of the lacrimal gland: clinicopathological, immunohistochemical and
molecular genetic analysis[ J]. Can J Ophthalmol, 2005, 40(2): 151-160.Farmer JP, Lamba M, Lamba WR, et al. Lymphoproliferative lesions
of the lacrimal gland: clinicopathological, immunohistochemical and
molecular genetic analysis[ J]. Can J Ophthalmol, 2005, 40(2): 151-160.
6、Ferreri AJ, Govi S, Pasini E, et al. Chlamydophila psittaci eradication
with doxycycline as first-line targeted therapy for ocular adnexae
lymphoma: final results of an international phase II trial[ J]. J Clin
Oncol, 2012, 30(24): 2988-2994.Ferreri AJ, Govi S, Pasini E, et al. Chlamydophila psittaci eradication
with doxycycline as first-line targeted therapy for ocular adnexae
lymphoma: final results of an international phase II trial[ J]. J Clin
Oncol, 2012, 30(24): 2988-2994.
7、Yoo C, Ryu MH, Huh J, et al. Chlamydia psittaci infection and
clinicopathologic analysis of ocular adnexal lymphomas in Korea[ J].
Am J Hematol, 2007, 82(9): 821-823.Yoo C, Ryu MH, Huh J, et al. Chlamydia psittaci infection and
clinicopathologic analysis of ocular adnexal lymphomas in Korea[ J].
Am J Hematol, 2007, 82(9): 821-823.
8、Cai JP, Cheng JW, Ma XY, et al. Lack of association of conjunctival
MALT lymphoma with Chlamydiae or Helicobacter pylori in a cohort of
Chinese patients[ J]. Med Sci Monit, 2012, 18(2): BR84-BR88.Cai JP, Cheng JW, Ma XY, et al. Lack of association of conjunctival
MALT lymphoma with Chlamydiae or Helicobacter pylori in a cohort of
Chinese patients[ J]. Med Sci Monit, 2012, 18(2): BR84-BR88.
9、Chen XY, Liu WZ, Shi Y, et al. Helicobacter pylori associated gastric
diseases and lymphoid tissue hyperplasia in gastric antral mucosa[ J]. J
Clin Pathol, 2002, 55(2): 133-137.Chen XY, Liu WZ, Shi Y, et al. Helicobacter pylori associated gastric
diseases and lymphoid tissue hyperplasia in gastric antral mucosa[ J]. J
Clin Pathol, 2002, 55(2): 133-137.
10、Usui Y, Rao NA, Takase H, et al. Comprehensive polymerase chain
reaction assay for detection of pathogenic DNA in lymphoproliferative
disorders of the ocular adnexa[ J]. Sci Rep, 2016, 6: 36621.Usui Y, Rao NA, Takase H, et al. Comprehensive polymerase chain
reaction assay for detection of pathogenic DNA in lymphoproliferative
disorders of the ocular adnexa[ J]. Sci Rep, 2016, 6: 36621.
11、Verdijk RM. Lymphoproliferative tumors of the ocular adnexa[ J]. Asia
Pac J Ophthalmol (Phila), 2017, 6(2): 132-142.Verdijk RM. Lymphoproliferative tumors of the ocular adnexa[ J]. Asia
Pac J Ophthalmol (Phila), 2017, 6(2): 132-142.
12、Asadi-Amoli F, Nozarian Z, Bonaki HN, et al. Clinicopathologic assessment
of ocular adnexal lymphoproliferative lesions at a tertiary eye hospital in
Iran[J]. Asian Pac J Cancer Prev, 2016, 17(8): 3727-3731.Asadi-Amoli F, Nozarian Z, Bonaki HN, et al. Clinicopathologic assessment
of ocular adnexal lymphoproliferative lesions at a tertiary eye hospital in
Iran[J]. Asian Pac J Cancer Prev, 2016, 17(8): 3727-3731.
13、McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal lymphoproliferative
disease: a series of 73 cases[J]. Clin Exp Ophthalmol, 2001, 29(6): 387-393.McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal lymphoproliferative
disease: a series of 73 cases[J]. Clin Exp Ophthalmol, 2001, 29(6): 387-393.
14、Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa:
A study of 353 cases[ J]. Am J Surg Pathol, 2007, 31(2): 170-184.Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa:
A study of 353 cases[ J]. Am J Surg Pathol, 2007, 31(2): 170-184.
15、渠晓黎. CD23和IgD在眼附属器淋巴组织增生性疾病的表达及
意义[D]. 青岛: 青岛大学, 2016.
QU XL. Establishment of a combination scoring method for
diagnosis of ocular adnexal lymphoproliferative disease[D]. Qingdao:
Qingdao University, 2016.渠晓黎. CD23和IgD在眼附属器淋巴组织增生性疾病的表达及
意义[D]. 青岛: 青岛大学, 2016.
QU XL. Establishment of a combination scoring method for
diagnosis of ocular adnexal lymphoproliferative disease[D]. Qingdao:
Qingdao University, 2016.
16、Qu XL, Hei Y, Kang L, et al. Establishment of a combination scoring
method for diagnosis of ocular adnexal lymphoproliferative disease[ J].
PLoS One, 2017, 12(5): e0160175.Qu XL, Hei Y, Kang L, et al. Establishment of a combination scoring
method for diagnosis of ocular adnexal lymphoproliferative disease[ J].
PLoS One, 2017, 12(5): e0160175.
17、Takahira M, Ozawa Y, Kawano M, et al. Clinical aspects of IgG4-related
orbital inflammation in a case series of ocular adnexal lymphoproliferative
disorders[ J]. Int J Rheumatol, 2012, 2012: 635473.Takahira M, Ozawa Y, Kawano M, et al. Clinical aspects of IgG4-related
orbital inflammation in a case series of ocular adnexal lymphoproliferative
disorders[ J]. Int J Rheumatol, 2012, 2012: 635473.
18、Andrew N, Kearney D, Selva D, et al. IgG4-related orbital disease: a
meta-analysis and review[ J]. Acta Ophthalmol, 2013, 91(8): 694-700.Andrew N, Kearney D, Selva D, et al. IgG4-related orbital disease: a
meta-analysis and review[ J]. Acta Ophthalmol, 2013, 91(8): 694-700.
19、Olsen TG, Heegaard S, et al. Orbital lymphoma[ J]. Surv Ophthalmol,
2019, 64(1): 45-66.Olsen TG, Heegaard S, et al. Orbital lymphoma[ J]. Surv Ophthalmol,
2019, 64(1): 45-66.
20、徐青, 肖利华, 何彦津, 等. 眼附属器黏膜相关淋巴组织型淋巴
瘤和反应性淋巴组织增生的鉴别诊断研究[ J]. 中华眼科杂志,
2004, 40(12): 6-10.
XU Q, XIAO LH, HE YJ, et al. Study on diferential diagnosis
between T-type lymphoma and reactive lymphoid hyperplasia of the ocular
adnexa[J]. Chinese Journal of Ophthalmology, 2004, 40(12): 6-10.徐青, 肖利华, 何彦津, 等. 眼附属器黏膜相关淋巴组织型淋巴
瘤和反应性淋巴组织增生的鉴别诊断研究[ J]. 中华眼科杂志,
2004, 40(12): 6-10.
XU Q, XIAO LH, HE YJ, et al. Study on diferential diagnosis
between T-type lymphoma and reactive lymphoid hyperplasia of the ocular
adnexa[J]. Chinese Journal of Ophthalmology, 2004, 40(12): 6-10.
21、Suimon Y, Kase S, Miura I, et al. Alteration of cell surface markers
CD38 and CD138 in lymphoproliferative disorders in the ocular
adnexa[ J]. Anticancer Res, 2020, 40(4): 2019-2023.Suimon Y, Kase S, Miura I, et al. Alteration of cell surface markers
CD38 and CD138 in lymphoproliferative disorders in the ocular
adnexa[ J]. Anticancer Res, 2020, 40(4): 2019-2023.
22、Takahashi H, Usui Y, Ueda S, et al. Genome-wide analysis of ocular
adnexal lymphoproliferative disorders using high-resolution single
nucleotide polymorphism array[ J]. Invest Ophthalmol Vis Sci, 2015,
56(6): 4156-4165.Takahashi H, Usui Y, Ueda S, et al. Genome-wide analysis of ocular
adnexal lymphoproliferative disorders using high-resolution single
nucleotide polymorphism array[ J]. Invest Ophthalmol Vis Sci, 2015,
56(6): 4156-4165.
23、朱梅刚. 淋巴组织反应性增生的病理诊断与鉴别诊断[ J]. 白血
病·淋巴瘤, 2018, 27(5): 303-304.
ZHU MG. Pathological diagnosis and differential diagnosis of
reactive hyperplasia in lymphoid tissues[ J]. Journal of Leukemia &
Lymphoma, 2018, 27(5): 303-304.朱梅刚. 淋巴组织反应性增生的病理诊断与鉴别诊断[ J]. 白血
病·淋巴瘤, 2018, 27(5): 303-304.
ZHU MG. Pathological diagnosis and differential diagnosis of
reactive hyperplasia in lymphoid tissues[ J]. Journal of Leukemia &
Lymphoma, 2018, 27(5): 303-304.
24、Amer A, Mafeld S, Saeed D, et al. Reactive lymphoid hyperplasia of the
liver and pancreas. A report of two cases and a comprehensive review of
the literature[ J]. Clin Res Hepatol Gastroenterol, 2012, 36(4): e71-e80.Amer A, Mafeld S, Saeed D, et al. Reactive lymphoid hyperplasia of the
liver and pancreas. A report of two cases and a comprehensive review of
the literature[ J]. Clin Res Hepatol Gastroenterol, 2012, 36(4): e71-e80.
25、Stacy RC, Jakobiec FA, Schoenfield L, et al. Unifocal and multifocal
reactive lymphoid hyperplasia vs follicular lymphoma of the ocular
adnexa[ J]. Am J Ophthalmol, 2010, 150(3): 412-426.e1.Stacy RC, Jakobiec FA, Schoenfield L, et al. Unifocal and multifocal
reactive lymphoid hyperplasia vs follicular lymphoma of the ocular
adnexa[ J]. Am J Ophthalmol, 2010, 150(3): 412-426.e1.
26、朱梅刚. 免疫组织化学在淋巴组织增生性病变病理诊断中的应
用[ J]. 白血病·淋巴瘤, 2017, 26(10): 629-630.
ZHU MG. Application of immunohistochemistry in pathological
diagnosis of lymphoproliferative lesions[ J]. Journal of Leukemia &
Lymphoma, 2017, 26(10): 629-630.朱梅刚. 免疫组织化学在淋巴组织增生性病变病理诊断中的应
用[ J]. 白血病·淋巴瘤, 2017, 26(10): 629-630.
ZHU MG. Application of immunohistochemistry in pathological
diagnosis of lymphoproliferative lesions[ J]. Journal of Leukemia &
Lymphoma, 2017, 26(10): 629-630.
27、游启生, 李彬, 周小鸽, 等. 112例眼附属器淋巴增生性病变临床
组织病理学初步分析[ J]. 中华眼科杂志, 2005, 41(10): 12-17.
YOU QS, LI B, ZHOU XG, et al. Clinical and pathological
features of 112 cases with ocular adnexal lymphoproliferative
lesions[ J]. Chinese Journal of Ophthalmology, 2005, 41(10): 12-17.28.游启生, 李彬, 周小鸽, 等. 112例眼附属器淋巴增生性病变临床
组织病理学初步分析[ J]. 中华眼科杂志, 2005, 41(10): 12-17.
YOU QS, LI B, ZHOU XG, et al. Clinical and pathological
features of 112 cases with ocular adnexal lymphoproliferative
lesions[ J]. Chinese Journal of Ophthalmology, 2005, 41(10): 12-17.28.
28、Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology
of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology
of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
29、Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic
criteria for IgG4-related disease (IgG4-RD), 2011[ J]. Mod Rheumatol,
2012, 22(1): 21-30.Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic
criteria for IgG4-related disease (IgG4-RD), 2011[ J]. Mod Rheumatol,
2012, 22(1): 21-30.
30、Mulay K, Aggarwal E, Honavar SG, et al. Clinicopathologic features of
orbital immunoglobulin G4-related disease (IgG4-RD): a case series
and literature review[ J]. Graefes Arch Clin Exp Ophthalmol, 2015,
253(5): 803-809.Mulay K, Aggarwal E, Honavar SG, et al. Clinicopathologic features of
orbital immunoglobulin G4-related disease (IgG4-RD): a case series
and literature review[ J]. Graefes Arch Clin Exp Ophthalmol, 2015,
253(5): 803-809.
31、Reynolds GL, Norris JH, Aslam S, et al. IgG4-related disease presenting
as posterior scleritis and vitritis, progressing to multifocal orbital
involvement[ J]. BMJ Case Rep, 2017, 2017: bcr-2017-219568.Reynolds GL, Norris JH, Aslam S, et al. IgG4-related disease presenting
as posterior scleritis and vitritis, progressing to multifocal orbital
involvement[ J]. BMJ Case Rep, 2017, 2017: bcr-2017-219568.
32、Prayson RA . Immunoglobulin G4-related ophthalmic disease
presenting as uveitis[ J]. J Clin Neurosci, 2015, 22(11): 1848-1849.Prayson RA . Immunoglobulin G4-related ophthalmic disease
presenting as uveitis[ J]. J Clin Neurosci, 2015, 22(11): 1848-1849.
33、Goto H, Takahira M, Azumi A, et al. Diagnostic criteria for IgG4-
related ophthalmic disease[ J]. Jpn J Oph-thalmol, 2015, 59(1): 1-7.Goto H, Takahira M, Azumi A, et al. Diagnostic criteria for IgG4-
related ophthalmic disease[ J]. Jpn J Oph-thalmol, 2015, 59(1): 1-7.
34、Ueda S, Usui Y, Nagai T, et al. Immunophenotypic profiles for
distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors[ J]. Jpn J Ophthalmol, 2017,
61(4): 354-360.Ueda S, Usui Y, Nagai T, et al. Immunophenotypic profiles for
distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors[ J]. Jpn J Ophthalmol, 2017,
61(4): 354-360.
35、Goto H, Ueda S, et al. Immunoglobulin G4-related ophthalmic disease
involving the sclera misdiagnosed as intraocular tumor: report of one
case[ J]. Ocul Oncol Pathol, 2016, 2(4): 285-288.Goto H, Ueda S, et al. Immunoglobulin G4-related ophthalmic disease
involving the sclera misdiagnosed as intraocular tumor: report of one
case[ J]. Ocul Oncol Pathol, 2016, 2(4): 285-288.
36、Li J, Ma JM, Ge X, et al. Role of IgG4 serology in identifying common orbital
lymphoproliferative disorders[J]. Int J Ophthalmol, 2016, 9(2): 275-277.Li J, Ma JM, Ge X, et al. Role of IgG4 serology in identifying common orbital
lymphoproliferative disorders[J]. Int J Ophthalmol, 2016, 9(2): 275-277.
37、赵莲, 陈建卓, 王红霞. 眼眶炎性假瘤的临床病理特征分析及治
疗效果观察[ J]. 眼科新进展, 2015, 35(8): 759-761.
ZHAO L, CHEN JZ, WANG HX. Clinical pathologic
analysis and therapeutic effects of orbital inflammatory pseudotumor[ J].
Recent Advances in Ophthalmology, 2015, 35(8): 759-761.赵莲, 陈建卓, 王红霞. 眼眶炎性假瘤的临床病理特征分析及治
疗效果观察[ J]. 眼科新进展, 2015, 35(8): 759-761.
ZHAO L, CHEN JZ, WANG HX. Clinical pathologic
analysis and therapeutic effects of orbital inflammatory pseudotumor[ J].
Recent Advances in Ophthalmology, 2015, 35(8): 759-761.
38、Gupta R , Khosroshahi A, Shinagare S, et al. Does autoimmune
pancreatitis increase the risk of pancreatic carcinoma?: a retrospective
analysis of pancreatic resections[ J]. Pancreas, 2013, 42(3): 506-510.Gupta R , Khosroshahi A, Shinagare S, et al. Does autoimmune
pancreatitis increase the risk of pancreatic carcinoma?: a retrospective
analysis of pancreatic resections[ J]. Pancreas, 2013, 42(3): 506-510.
39、Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-related disease
with history of malignancy[ J]. Arthritis Rheumatol, 2016, 68(9):
2283-2289.Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-related disease
with history of malignancy[ J]. Arthritis Rheumatol, 2016, 68(9):
2283-2289.
40、Peng X, Jing H, He W, et al. Bilateral IgG4-related ophthalmic disease
with diffuse large B-cell lymphoma of the right eye: a case report[ J].
Ophthalmic Plast Reconstr Surg, 2020, 36(4): e84-e85.Peng X, Jing H, He W, et al. Bilateral IgG4-related ophthalmic disease
with diffuse large B-cell lymphoma of the right eye: a case report[ J].
Ophthalmic Plast Reconstr Surg, 2020, 36(4): e84-e85.
41、陈乐真. 手术中病理诊断图鉴[M]. 2版. 北京: 科学技术文献出
版社, 2015: 666-670.
CEHN LZ. In-traoperative pathology diagnostic illustrations[M].
2nd ed. Beijing: Science and Technology Literature Press, 2015: 666-670.陈乐真. 手术中病理诊断图鉴[M]. 2版. 北京: 科学技术文献出
版社, 2015: 666-670.
CEHN LZ. In-traoperative pathology diagnostic illustrations[M].
2nd ed. Beijing: Science and Technology Literature Press, 2015: 666-670.
42、陈莉, 周士东. 病理学[M]. 双语版, 3版. 北京: 科学出版社, 2016:
240-264.
CHEN L, ZHOU SD. Pathology[M]. Bilingual edition, 3rd ed.
Beijing: Science Press, 2016: 240-264.陈莉, 周士东. 病理学[M]. 双语版, 3版. 北京: 科学出版社, 2016:
240-264.
CHEN L, ZHOU SD. Pathology[M]. Bilingual edition, 3rd ed.
Beijing: Science Press, 2016: 240-264.
43、Norton AJ.Monoclonal antibodies in the diagnosis of
lymphoproliferative diseases of the orbit and orbital adnexae[ J]. Eye
(Lond), 2006, 20(10): 1186-1188.Norton AJ.Monoclonal antibodies in the diagnosis of
lymphoproliferative diseases of the orbit and orbital adnexae[ J]. Eye
(Lond), 2006, 20(10): 1186-1188.
44、陈平圣, 冯振卿, 刘慧. 病理学[M]. 2版. 南京: 东南大学出版社,
2017: 186-197.
CHEN PS, FENG ZQ, LIU H. Pathology[M]. 2nd ed.
Nanjing: Southeast University Press, 2017: 186-197.陈平圣, 冯振卿, 刘慧. 病理学[M]. 2版. 南京: 东南大学出版社,
2017: 186-197.
CHEN PS, FENG ZQ, LIU H. Pathology[M]. 2nd ed.
Nanjing: Southeast University Press, 2017: 186-197.
45、Yoshino T, Tanaka T, Sato Y, et al. Differential diagnosis of chronic
lymphocytic leukemia/small lymphocytic lymphoma and other
indolent lymphomas, including mantle cell lymphoma[ J]. J Clin Exp
Hematop, 2020, 60(4): 124-129.Yoshino T, Tanaka T, Sato Y, et al. Differential diagnosis of chronic
lymphocytic leukemia/small lymphocytic lymphoma and other
indolent lymphomas, including mantle cell lymphoma[ J]. J Clin Exp
Hematop, 2020, 60(4): 124-129.
46、何建芳, 韩安家, 吴秋良. 实用免疫组织化学病理诊断[M]. 北京:
科学出版社, 2018. 295-335.
HE JF, HAN AJ, WU QL. Practical immunohistochemical
pathological diagnosis[M]. Beijing: Science Press, 2018: 295-335.何建芳, 韩安家, 吴秋良. 实用免疫组织化学病理诊断[M]. 北京:
科学出版社, 2018. 295-335.
HE JF, HAN AJ, WU QL. Practical immunohistochemical
pathological diagnosis[M]. Beijing: Science Press, 2018: 295-335.
47、Tees MT, Flinn IW. Chronic lymphocytic leukemia and small
lymphocytic lymphoma: two faces of the same disease[ J]. Expert Rev
Hematol, 2017, 10(2): 137-146.Tees MT, Flinn IW. Chronic lymphocytic leukemia and small
lymphocytic lymphoma: two faces of the same disease[ J]. Expert Rev
Hematol, 2017, 10(2): 137-146.
48、王莉芬. 病理学(高级医师进阶副主任医师/主任医师)[M]. 2版.
北京: 中国协和医科大学出版社, 2020: 217-246.
WANG LF. Pathology advanced senior physician associate chief
physician/chief physician[M]. 2nd ed. Beijing: Peking Union Medical
College Press, 2020: 217-246.王莉芬. 病理学(高级医师进阶副主任医师/主任医师)[M]. 2版.
北京: 中国协和医科大学出版社, 2020: 217-246.
WANG LF. Pathology advanced senior physician associate chief
physician/chief physician[M]. 2nd ed. Beijing: Peking Union Medical
College Press, 2020: 217-246.
49、Sander B. Mantle cell lymphoma: recent insights into pathogenesis,
clinical variability, and new diagnostic markers[ J]. Semin Diagn Pathol,
2011, 28(3): 245-255.Sander B. Mantle cell lymphoma: recent insights into pathogenesis,
clinical variability, and new diagnostic markers[ J]. Semin Diagn Pathol,
2011, 28(3): 245-255.
50、Vali Khojeini E, Durham BH, Chen M, et al. Mantle cell lymphoma and
involvement of the orbit and ocular adnexa[ J]. Case Rep Pathol, 2013,
2013: 581856.Vali Khojeini E, Durham BH, Chen M, et al. Mantle cell lymphoma and
involvement of the orbit and ocular adnexa[ J]. Case Rep Pathol, 2013,
2013: 581856.
51、Espinoza GM. Orbital inflammator y pseudotumors: etiology,
differential diagnosis, and management[ J]. Curr Rheumatol Rep, 2010,
12(6): 443-447.Espinoza GM. Orbital inflammator y pseudotumors: etiology,
differential diagnosis, and management[ J]. Curr Rheumatol Rep, 2010,
12(6): 443-447.
52、Devaney KO, Lafeir DJ, Triantafyllou A, et al. Inflammatory myofibroblastic
tumors of the head and neck: evaluation of clinicopathologic and prognostic
features[J]. Eur Arch Otorhinolaryngol, 2012, 269(12): 2461-2465.Devaney KO, Lafeir DJ, Triantafyllou A, et al. Inflammatory myofibroblastic
tumors of the head and neck: evaluation of clinicopathologic and prognostic
features[J]. Eur Arch Otorhinolaryngol, 2012, 269(12): 2461-2465.
53、Swamy BN, McCluskey P, Nemet A , et al. Idiopathic orbital
inflammatory syndrome: clinical features and treatment outcomes[ J].
Br J Ophthalmol, 2007, 91(12): 1667-1670.Swamy BN, McCluskey P, Nemet A , et al. Idiopathic orbital
inflammatory syndrome: clinical features and treatment outcomes[ J].
Br J Ophthalmol, 2007, 91(12): 1667-1670.
54、Kansara S, Bell D, Johnson J, et al. Head and neck inflammatory
pseudotumor: Case series and review of the literature[ J]. Neuroradiol J,
2016, 29(6): 440-446.Kansara S, Bell D, Johnson J, et al. Head and neck inflammatory
pseudotumor: Case series and review of the literature[ J]. Neuroradiol J,
2016, 29(6): 440-446.
55、Rath S, Connors JM, Dolman PJ, et al. Comparison of American Joint
Committee on Cancer TNM-based staging system (7th edition) and
Ann Arbor classification for predicting outcome in ocular adnexal
lymphoma [ J]. Orbit, 2014, 33 (1): 23-28.Rath S, Connors JM, Dolman PJ, et al. Comparison of American Joint
Committee on Cancer TNM-based staging system (7th edition) and
Ann Arbor classification for predicting outcome in ocular adnexal
lymphoma [ J]. Orbit, 2014, 33 (1): 23-28.
56、Dhakal B, Fenske TS, Ramalingam S, et al. Local disease control in
ocular adnexal lymphoproliferative disorders: comparative outcomes
of MALT versus non-MALT histologies[ J]. Clin Lymphoma Myeloma
Leuk, 2017, 17(5): 305-311.e2.Dhakal B, Fenske TS, Ramalingam S, et al. Local disease control in
ocular adnexal lymphoproliferative disorders: comparative outcomes
of MALT versus non-MALT histologies[ J]. Clin Lymphoma Myeloma
Leuk, 2017, 17(5): 305-311.e2.
57、Maritati F, Peyronel F, Vaglio A, et al. IgG4-related disease: a clinical
perspective[J]. Rheumatology (Oxford), 2020, 59(Suppl 3): iii123-iii131.Maritati F, Peyronel F, Vaglio A, et al. IgG4-related disease: a clinical
perspective[J]. Rheumatology (Oxford), 2020, 59(Suppl 3): iii123-iii131.